Skip to main content
. 2022 Aug 12;118(1):105–113. doi: 10.14309/ajg.0000000000001937

Table 5.

(a) Overall baseline characteristics and clinical outcomes of patients without infection who were alive at discharge and prescribed rifaximin or not and (b) analyses with propensity score matching

graphic file with name acg-118-105-g005.jpg